• Je něco špatně v tomto záznamu ?

Long-term outcome of kidney function in patients with ANCA-associated vasculitis

B. Sachez-Alamo, L. Moi, I. Bajema, A. Berden, O. Flossmann, Z. Hruskova, D. Jayne, M. Wester-Trejo, C. Wallquist, K. Westman

. 2024 ; 39 (9) : 1483-1493. [pub] 20240830

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24019238

Grantová podpora
European Renal Association
Vasculitis Foundation
REG-SKANE_924921 Region Skane
Njurfonden
Swedish Kidney Fund

BACKGROUND: Kidney involvement is common in anti-neutrophil cytoplasm antibody-associated vasculitis (AAV) and the prognosis is determined by the severity of kidney damage. This study focused on long-term kidney outcomes, defining possible risk factors and comparing the performance of three different histological classifications to predict outcomes for patients with AAV. METHODS: The dataset included 848 patients with newly diagnosed AAV who participated in seven randomized controlled trials (RCTs) (1995-2012). Follow-up information was obtained from questionnaires sent to the principal investigators of the original RCTs. RESULTS: The cumulative incidence of end-stage kidney disease (ESKD) at 5 and 10 years was 17% and 22%, respectively. Patients who developed ESKD had reduced patient survival compared with those with preserved kidney function (hazard ratio 2.8, P < .001). Comparing patients with AAV and kidney involvement with a matched general population, patients with AAV had poor survival outcomes, even in early stages of chronic kidney disease. The main cause of death was infection followed by cardiovascular disease in patients developing ESKD and malignancy in those who did not. Some 34% of patients with initial need for dialysis recovered kidney function after treatment. Thirty-five out of 175 in need of kidney replacement therapy (KRT) during follow-up received a kidney transplant with good outcome; there was 86% patient survival at 10 years.In the subcohort of 214 patients with available kidney biopsies, three scoring systems were tested: the Berden classification, the Renal Risk Score and the Mayo Clinic Score. The scores highlighted the importance of normal glomeruli and severe glomerulosclerosis on kidney survival (P < .001 and P = .001, respectively). The Renal Risk Score demonstrated a moderate prediction of kidney survival (area under the curve 0.79; standard error 0.03, 95% confidence interval 0.71-0.83). CONCLUSIONS: Early diagnosis of AAV is extremely important. Even milder forms of kidney involvement have an impact on the prognosis. Patients in need of KRT had the lowest survival rates, but kidney transplantation has shown favorable outcomes for eligible AAV patients. The three histologic scoring systems were all identified as independent prognostic factors for kidney outcome.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24019238
003      
CZ-PrNML
005      
20241024111402.0
007      
ta
008      
241015s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/ndt/gfae018 $2 doi
035    __
$a (PubMed)38268409
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Sachez-Alamo, Beatriz $u Department of Clinical Sciences Lund, Division of Nephrology, Lund University, Sweden $u Department Nephrology, Hospital Universitario del Sureste, Arganda del Rey, Madrid, Spain
245    10
$a Long-term outcome of kidney function in patients with ANCA-associated vasculitis / $c B. Sachez-Alamo, L. Moi, I. Bajema, A. Berden, O. Flossmann, Z. Hruskova, D. Jayne, M. Wester-Trejo, C. Wallquist, K. Westman
520    9_
$a BACKGROUND: Kidney involvement is common in anti-neutrophil cytoplasm antibody-associated vasculitis (AAV) and the prognosis is determined by the severity of kidney damage. This study focused on long-term kidney outcomes, defining possible risk factors and comparing the performance of three different histological classifications to predict outcomes for patients with AAV. METHODS: The dataset included 848 patients with newly diagnosed AAV who participated in seven randomized controlled trials (RCTs) (1995-2012). Follow-up information was obtained from questionnaires sent to the principal investigators of the original RCTs. RESULTS: The cumulative incidence of end-stage kidney disease (ESKD) at 5 and 10 years was 17% and 22%, respectively. Patients who developed ESKD had reduced patient survival compared with those with preserved kidney function (hazard ratio 2.8, P < .001). Comparing patients with AAV and kidney involvement with a matched general population, patients with AAV had poor survival outcomes, even in early stages of chronic kidney disease. The main cause of death was infection followed by cardiovascular disease in patients developing ESKD and malignancy in those who did not. Some 34% of patients with initial need for dialysis recovered kidney function after treatment. Thirty-five out of 175 in need of kidney replacement therapy (KRT) during follow-up received a kidney transplant with good outcome; there was 86% patient survival at 10 years.In the subcohort of 214 patients with available kidney biopsies, three scoring systems were tested: the Berden classification, the Renal Risk Score and the Mayo Clinic Score. The scores highlighted the importance of normal glomeruli and severe glomerulosclerosis on kidney survival (P < .001 and P = .001, respectively). The Renal Risk Score demonstrated a moderate prediction of kidney survival (area under the curve 0.79; standard error 0.03, 95% confidence interval 0.71-0.83). CONCLUSIONS: Early diagnosis of AAV is extremely important. Even milder forms of kidney involvement have an impact on the prognosis. Patients in need of KRT had the lowest survival rates, but kidney transplantation has shown favorable outcomes for eligible AAV patients. The three histologic scoring systems were all identified as independent prognostic factors for kidney outcome.
650    _2
$a lidé $7 D006801
650    12
$a ANCA-asociované vaskulitidy $x komplikace $x mortalita $x terapie $7 D056648
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prognóza $7 D011379
650    _2
$a následné studie $7 D005500
650    12
$a chronické selhání ledvin $x mortalita $x terapie $x etiologie $7 D007676
650    _2
$a míra přežití $7 D015996
650    _2
$a hodnoty glomerulární filtrace $7 D005919
650    _2
$a rizikové faktory $7 D012307
650    _2
$a vyšetření funkce ledvin $7 D007677
650    _2
$a senioři $7 D000368
650    _2
$a dospělí $7 D000328
655    _2
$a časopisecké články $7 D016428
700    1_
$a Moi, Laura $u Division of Immunology and Allergy Department of Medicine, University Hospital of Lausanne, Lausanne University, Lausanne, Switzerland
700    1_
$a Bajema, Ingeborg $u Department of Pathology, Groningen, The Netherlands
700    1_
$a Berden, Annelies $u Department of Rheumatology and Clinical Immunology, Maasstad Hospital, Rotterdam, The Netherlands
700    1_
$a Flossmann, Oliver $u Department of Nephrology, Royal Berkshire Hospital, Reading, UK
700    1_
$a Hruskova, Zdenka $u Department of Nephrology, General Hospital in Prague and First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Jayne, David $u Department of Medicine, University of Cambridge, Cambridge, UK
700    1_
$a Wester-Trejo, Maria $u Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands
700    1_
$a Wallquist, Carin $u Department of Nephrology, Skane Univ. Hospital Malmö, Malmö, Sweden
700    1_
$a Westman, Kerstin $u Department of Clinical Sciences Lund, Division of Nephrology, Lund University, Lund, Sweden
773    0_
$w MED00010288 $t Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association $x 1460-2385 $g Roč. 39, č. 9 (2024), s. 1483-1493
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38268409 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024111356 $b ABA008
999    __
$a ok $b bmc $g 2201848 $s 1231211
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 39 $c 9 $d 1483-1493 $e 20240830 $i 1460-2385 $m Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association $n Nephrol Dial Transplant $x MED00010288
GRA    __
$p European Renal Association
GRA    __
$p Vasculitis Foundation
GRA    __
$a REG-SKANE_924921 $p Region Skane
GRA    __
$p Njurfonden
GRA    __
$p Swedish Kidney Fund
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Možnosti archivace